Physician profile
Emy C Chen
NPI 1689741910
$4,257.00
in general payments reported to CMS, 2019-2025
19 companies · $495 in 2025
The $495 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,931 · 2020: $534 · 2021: $212 · 2022: $244 · 2023: $184 · 2024: $657 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,258 · Education: $77.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,257.92 |
| Education | $77.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,480.86 | 2019-2025 | |
| Amgen INC. | $926.25 | 2019-2025 | Enbrel, Otezla, Evenity |
| Janssen Biotech, INC. | $377.64 | 2019-2024 | Tremfya |
| Glaxosmithkline, LLC. | $206.90 | 2019-2024 | Benlysta |
| Abbvie INC. | $200.78 | 2019-2024 | |
| Mallinckrodt Enterprises LLC | $197.29 | 2019 | |
| Celgene Corporation | $150.60 | 2019 | |
| Lilly USA, LLC | $143.23 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $114.94 | 2019-2025 | |
| Ucb, INC. | $111.06 | 2019-2020 | |
| Medexus Pharma, INC. | $66.53 | 2019 | |
| Genentech USA, INC. | $56.54 | 2019 | |
| Bioventus LLC | $48.21 | 2020 | |
| Horizon Therapeutics Plc | $46.27 | 2019 | |
| Sobi, INC | $42.26 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.83 | 2020 | |
| Radius Health, INC. | $20.95 | 2019 | |
| Boston Scientific Corporation | $20.12 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $14.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emy Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.